Skip to content

Bioavailability Study of Cretan Carob

Bioavailability of Phenolic Compounds Following the Consumption of a Carob Beverage

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05870930
Acronym
BIOCRETANCAROB
Enrollment
15
Registered
2023-05-23
Start date
2024-02-10
Completion date
2025-03-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Diet

Keywords

carob, phenolic compound bioavailability, metabolites, bioavailability in humans, Imera carob

Brief summary

This is an interventional, open-label, single-group, bioavailability postprandial study. The aim of the study is to evaluate the bioavailability of phenolic compounds of a beverage prepared with Cretan carob powder of the Imera cultivar in healthy individuals after consumption.

Detailed description

This is an interventional, open-label, single-group, bioavailability postprandial study. The aim of the study is to evaluate the bioavailability of active constituents of a beverage with carob powder in healthy individuals after consumption. Fifteen apparently healthy male adults of normal body fat mass (non-obese) will be enrolled based on certain inclusion and exclusion criteria. After enrollment, the volunteers will undergo a medical and dietary assessment and will be instructed to follow a low-phytochemical diet (washout) for five consecutive days, excluding from their diet sources of phytochemicals, i.e., fruits, vegetables, legumes, coffee, tea. Compliance with the low-phytochemical diet will be assessed with a 24 h recall during and at the end of the washout period. On the day of the experiment following washout, volunteers will be given a carob beverage (blood samples will be collected 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0h postprandially). Time intervals 0-6h will be used for LC-ESI-MS/MS approach in order to identify putative polyphenol metabolites related to carob consumption.

Interventions

Volunteers will consume 2 tablespoons of carob powder in 200mL drinking water.

Sponsors

Harokopio University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy male adults * normal body fat mass

Exclusion criteria

* obesity (according to body fat mass) * Type 1 Diabetes, cardiovascular diseases, hypertension * thyroid disorder, liver disease, kidney disease * gastrointestinal disease * mental illness * use of nutraceutical supplements or natural products for weight loss * dietitians/nutritionists

Design outcomes

Primary

MeasureTime frameDescription
Identification of putative polyphenol metabolites related to carob consumption.Six hoursPolyphenol metabolites related to carob consumption identified using LC-ESI-MS/MS.

Countries

Greece

Contacts

PRINCIPAL_INVESTIGATORAndriana C Kaliora

Harokopio University of Athens, Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026